Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality. | Circulation;103(6): 889-96, 2001 Feb 13. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality.

Dash, R; Kadambi, V; Schmidt, A G; Tepe, N M; Biniakiewicz, D; Gerst, M J; Canning, A M; Abraham, W T; Hoit, B D; Liggett, S B; Lorenz, J N; Dorn, G W; Kranias, E G.

Affiliation

Dash R; Department of Cardiovascular Biology, Millennium Pharmaceuticals Inc, Cambridge, Massachusetts, USA.

Circulation ; 103(6): 889-96, 2001 Feb 13.

Article in En | MEDLINE | ID: mdl-11171800

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Calcium-Binding Proteins / Aging / Receptors, Adrenergic, beta / Cardiomyopathies Type of study: Etiology_studies Limits: Animals Language: En Journal: Circulation Year: 2001 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Calcium-Binding Proteins / Aging / Receptors, Adrenergic, beta / Cardiomyopathies Type of study: Etiology_studies Limits: Animals Language: En Journal: Circulation Year: 2001 Document type: Article Affiliation country: Country of publication: